Eli Lilly Shares Sink, Qualcomm's Tepid Forecast, Carrier Global Rises

Stock Movers

On this episode of Stock Movers:

- Eli Lilly (LLY) shares fell the most intraday since October after CVS Health announced a plan to drop its blockbuster weight-loss drug Zepbound from its preferred list, making rival Wegovy more widely available. While the company maintained its sales guidance between $58 billion and $61 billion for the year, and Zepbound performed in line with Wall Street’s expectations, investors who had been hoping for more explosive growth were underwhelmed.

- Qualcomm (QCOM) shares fell after the company gave a tepid revenue forecast, underscoring concerns that tariffs will hurt demand for its products. Revenue in the period ending in June will be $9.9 billion to $10.7 billion, the company said Wednesday in a statement. The midpoint of that range was slightly below the average analyst estimate of $10.33 billion.

- Carrier Global Corp. (CARR) shares are up. The company said said its tariff exposure has been alleviated in part through price increases, allowing it to boost its full-year profit outlook and sending its shares higher. The HVAC company is fully mitigating the impact of tariffs that are in effect today, it said in a statement Thursday. “We are fully mitigating our tariff exposure through supply chain and productivity actions with the balance of about $300 million via price, which represents a little over 1% of additional pricing,” Chief Executive Officer Dave Gitlin said on a call with investors.

See omnystudio.com/listener for privacy information.

2025-05-01 5 min Transcript

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.